Quantitative PCR based minimal residual disease detection in core binding factor leukemias: prognostication and guiding of therapy

Leuk Res. 2006 Jun;30(6):657-8. doi: 10.1016/j.leukres.2005.11.002. Epub 2005 Dec 28.

Authors

Susanne Schnittger, Claudia Schoch

PMID: 16386301
DOI: 10.1016/j.leukres.2005.11.002

No abstract available

Publication types

Editorial
Comment

MeSH terms

Core Binding Factor Alpha 2 Subunit / genetics*
Humans
Leukemia, Myeloid, Acute / diagnosis*
Leukemia, Myeloid, Acute / genetics
Monitoring, Physiologic / methods
Neoplasm, Residual
Oncogene Proteins, Fusion / genetics*
Polymerase Chain Reaction* / methods
Predictive Value of Tests
Prognosis
RUNX1 Translocation Partner 1 Protein

Substances

AML1-ETO fusion protein, human
CBFbeta-MYH11 fusion protein
Core Binding Factor Alpha 2 Subunit
Oncogene Proteins, Fusion
RUNX1 Translocation Partner 1 Protein